1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy
(
- Contribution to journal › Article
- 2022
-
Mark
Reprogramming primary melanoma cells to dendritic cell fate enhances tumor immunogenicity
2022) SITC Society for Immunotherapy of Cancer 2022(
- Contribution to conference › Poster
- 2021
-
Mark
Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
(
- Contribution to journal › Article